Editorial: Drug-ability strategies for potential antimycobacterial candidate: opportunities and challenges

Shasank Sekhar Swain; Sunday Oyedemi; Sudhir Kumar Paidesetty; Soumitra Mohanty; Tahziba Hussain

doi:10.3389/fphar.2023.1294912

Editorial: Drug-ability strategies for potential antimycobacterial candidate: opportunities and challenges

Front Pharmacol. 2023 Nov 14:14:1294912. doi: 10.3389/fphar.2023.1294912. eCollection 2023.

Authors

Shasank Sekhar Swain¹, Sunday Oyedemi², Sudhir Kumar Paidesetty³, Soumitra Mohanty⁴, Tahziba Hussain¹

Affiliations

¹ Division of Microbiology and NCDs, Regional Medical Research Centre, Bhubaneswar, Odisha, India.
² Department of Pharmacology, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom.
³ Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Siksha "O" Anusandhan University, Bhubaneswar, Odisha, India.
⁴ Division of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.

No abstract available

Keywords: anti-TB drug development; bioinformatics tools; drug development strategies against tuberculosis; medicinal chemistry and drug synthesis; natural product-based drug discovery.

Publication types

Editorial